Board to Consider GSK Fluarix Vaccine Purchase
Champaign Urbana Public Health DistrictPublic Health · Champaign, IL- Document date
- Oct 21, 2026
The 30-second brief
The Champaign-Urbana Public Health District Board of Health is scheduled to consider a check request to GlaxoSmithKline Pharmaceuticals (GSK) for Fluarix TIV PFS. The agenda does not state the purchase amount.
Glaxosmithkline Pharmaceuticals (Gsk) holds this supplies contract with Champaign Urbana Public Health District.
Hear about the next contract at Champaign Urbana Public Health District early.
Get pre-RFP alerts freeFree account · 30-second setup · No credit card
Contract details
- Contract type
- Supplies
- Document date
- October 21, 2026
- Vendor
- Glaxosmithkline Pharmaceuticals (Gsk)
- Source document
- Champaign-Urbana Public Health District Agenda Board of Health Monthly Meeting 2026-10-21 (Agenda)
More Champaign Urbana Public Health District contracts
Questions about this contract
Who was awarded the supplies contract by Champaign Urbana Public Health District?
Glaxosmithkline Pharmaceuticals (Gsk) was awarded this supplies contract by Champaign Urbana Public Health District, as recorded on October 21, 2026.
What type of contract is this?
This is a Supplies contract, documented as a agenda record.
Where was this contract approved?
This contract appears in Champaign-Urbana Public Health District Agenda Board of Health Monthly Meeting 2026-10-21 (Agenda), dated October 21, 2026 from Champaign Urbana Public Health District. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What is Champaign Urbana Public Health District currently buying?
Explore Champaign Urbana Public Health District's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.